Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes

Circulation

Volumn 122, Issue 7, 2010, Pages 698-706

  Pelliccia, Antonio ^a   Di Paolo, Fernando M ^a   De Blasiis, Elvira ^a   Quattrini, Filippo M ^a   Pisicchio, Cataldo ^a   Guerra, Emanuele ^a   Culasso, Franco ^b   Maron, Barry J ^c  

^a Italian National Olympic Committee   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c MINNEAPOLIS HEART INSTITUTE FOUNDATION   (United States)

Author keywords

aorta; competitive athletes; echocardiography; remodeling

Indexed keywords

ADAPTATION; ADOLESCENT; ADULT; AGE DISTRIBUTION; ANALYTICAL PARAMETERS; AORTA DISEASE; AORTA ROOT; AORTIC ROOT DILATION; ARTICLE; ATHLETE; BODY HEIGHT; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; EXERCISE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; SPORT;

ADOLESCENT; ADULT; AORTIC VALVE; ATHLETES; ATHLETIC PERFORMANCE; CHILD; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; FOLLOW-UP STUDIES; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 77955982419     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.901074     Document Type: Article

References (35)

1. Maron BJ, Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation. 2006;114: 1633-1644.
2. Pelliccia A, Maron BJ, Spataro A, Proshan M, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med. 1991;324:295-301.
3. Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. The athlete's heart in women: echocardiographic characterization of 600 highly trained and elite female athletes. JAMA. 1996;276:211-215.
4. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med. 1999;130: 23-31.
5. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, Pisicchio C, Roselli A, Caselli S, Culasso F. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol. 2005; 46:690-696.
6. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardio-myopathy. Circulation. 1995;91:1596-1601.
7. Maron BJ, Ackermann MJ, Nishimura RA, Pyeritz RE, Towbin JA Udelson JE. 36th Bethesda Conference, Task Force 4: other cardiomy-opathies, mitral valve prolapse, myocarditis, and Marfan syndrome. J Am Coll Cardiol. 2005;45:1340-1345.
8. Roman MJ, Devereux RB, Kramer-Fox R, O'Louhhlin J, Spitzer M, Robins J. Two dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol. 1989;64:507-512.
9. Vasan RS, Larson MG, Levy D. Determinants of echocardiographic aortic root size: the Framingham Heart Study. Circulation. 1995;91: 734-740.
10. Pelliccia A, Maron BJ. Preparticipation cardiovascular evaluation of the competitive athlete: perspectives from the 30-year Italian experience. Am J Cardiol. 1995;75:827-829.
11. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echo-cardiographic measurements. Circulation. 1978;58:1072-1083.
12. Yeung AC, Plappert T, Sutton MG. Calculation of aortic regurgitation orifice area by Doppler echocardiography: an application of the continuity equation. Br Heart J. 1992;68:236-240.
13. Spirito P, Maron BJ. Doppler echocardiography for assessing left ventricular diastolic function. Ann Intern Med. 1988;109:122-126.
14. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised criteria for Marfan syndrome. Am J Med Genet. 1996;62: 417-426.
15. Freed LA, Benjamin EJ, Levy D, Larson MG, Evans JC, Fuller DL, Lehman B, Levine RA. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. J Am Coll Cardiol. 2002;40:1298-1304.
16. Armitage P, Berry G. Statistical Methods in Medical Research. Oxford, UK: McGraw-Hill Publishers; 1998:157-175.
17. Clifford PS, Hanel B, Secher NH. Arterial blood pressure response to rowing. Med Sci Sports Exerc. 1994;26:715-719.
18. Palatini P. Exercise haemodynamics: field activities versus laboratory tests. Blood Press Monit. 1997;2:133-137.
19. Copeland SR, Mills MC, Lerner JL, Crizer MF, Thompson CW, Sullivan JM. Hemodynamic effects of aerobic vs. resistance exercise. J Hum Hypertens. 1996;10:747-753.
20. Hill DW, Butler SD. Hemodynamic responses to weightlifting exercise. Sports Med. 1991;12:1-7.
21. Babaee Bigi MA, Aslani A. Aortic root size and prevalence of aortic regurgitation in elite strength trained athletes. Am J Cardiol. 2007;100: 528-530.
22. Maron BJ. Sudden death in young athletes. N Engl J Med. 2003;349: 1064-1075.
23. Tadros TM, Klein MD, Shapira OM. Ascending aortic dilatation associated with bicuspid aortic valve: pathophysiology, molecular biology, and clinical implications. Circulation. 2009;119:880-890.
24. Demak R. Marfan syndrome: a silent killer. Sports Illustrated. 1986;64: 30-35.
25. Pearce F. "Why did he die?" The Guardian. May 17, 2005. Available at: http//www.societyguardian.co.uk. Accessed March 23, 2010.
26. Luciano Vendemini. Available at: http://www.archiviostorico.corriere.it/ 1997/august/26. Accessed March 23, 2010.
27. Coady MA, Rizzo JA, Hammond GL, Kopf GS, Elefteriades JA. Surgical intervention criteria for thoracic aortic aneurysms: a study of growth rates and complications. Ann Thorac Surg. 1999;67:1922-1926.
28. Kinoshita N, Mimura J, Obayashi C, Katsukawa F, Onishi S, Yamazaki H. Aortic root dilatation among young competitive athletes: echocardio-graphic screening of 1929 athletes between 15 and 34 years of age. Am Heart J. 2000;139:723-728.
29. Ergin MA, Speilvogel D, Apaydin A, Lansman SL, McCullough JN, Galla JD, Griepp RB. Surgical treatment of the dilated ascending aorta: when and how? Ann Thorac Surg. 1999;67:1834-1839.
30. Bonow RO, Carabello BA, Chatterjee K, de Leon AC, Faxon DP, Freed MD, Gaasch WH, Lytle BW, Nishimura RA, O'Gara PT, O'Rourke RA, Otto CM, Shah PM, Shanewise JS, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Page RL, Riegel B. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol. 2006;48;e1-e148.
31. Vasan RS, Larson MG, Benjamin EJ, Levy D. Echocardiographic reference values for aortic root size: the Framingham Heart Study. J Am Soc Echocardiogr. 1995;8:793-800.
32. Yetman AT, Graham T. The dilated aorta in patients with congenital cardiac defects. J Am Coll Cardiol. 2009;53:461-467.
33. Biner S, Rafique AM, Ray I, Cuk O, Siegel RJ, Tolstrup K. Aortopathy is prevalent in relatives of bicuspid aortic valve patients. J Am Coll Cardiol. 2009;53:2288-2295.
34. Pelliccia A, Zipes DP, Maron BJ. Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. J Am Coll Cardiol. 2008;52:1990-1996.
35. Pelliccia A, Spataro A, Caselli G, Maron BJ. Absence of left ventricular wall thickening in athletes engaged in intense power training. Am J Cardiol. 1993;72:1048-1054.